House dust mite allergy, also known as dust mite allergy or dust allergy, is an allergic reaction triggered by the proteins found in the feces, body parts and secretions of dust mites. Dust mites are microscopic arthropods that thrive in indoor environments, particularly in warm, humid conditions. They are commonly found in bedding, upholstered furniture, carpets, curtains and other soft furnishings where they feed on dead skin cells shed by humans and pets.
The house dust mite allergy market consists of sales, by entities (organizations, sole traders and partnerships), of house dust mite allergy treatment products designed to either reduce exposure to allergens or to treat the symptoms and underlying immune response.
The global house dust mite allergy market was valued at $1,235.85 million in 2018 to $1,898.01 million in 2023 at a compound annual growth rate (CAGR) of more than 8.0%.
Rising Air Pollution Levels
The surge in air pollution levels propelled the expansion of the house dust mite allergy market throughout the historic period. Air pollution refers to the presence of harmful substances, such as particulate matter, gases and pollutants, in the earth's atmosphere, resulting in adverse effects on human health, ecosystems and the climate. The ascent in air pollution was attributed to increased industrial activities, vehicular emissions, urbanization and agricultural practices, all of which contributed to elevated levels of pollutants in the atmosphere during the historic period. Air pollution can exacerbate house dust mite allergies by increasing the prevalence of fine particulate matter and pollutants, providing a conducive environment for mite proliferation and intensifying allergic reactions. According to the Office for National Statistics, a UK-based independent producer of official statistics, the UK experienced a 2% increase in greenhouse gas (GHG) emissions on a residential basis between 2021 and 2022 (provisional data), marking a continuation of the 3% rise observed in 2021 following the levels seen in 2020. Therefore, the rise in air pollution levels drove the growth of the house dust mite allergy market.
Increased Focus On Novel Drug Development For House Dust Mite Allergies
Companies in the house dust mite allergy market are developing advanced allergen products, such as house dust mite allergen extract tablets, to enhance treatment options for individuals with this allergic condition. These products aim to provide effective therapeutic solutions for individuals with house dust mite allergies. For instance, in January 2023, ALK, a US-based research-driven pharmaceutical company, received US Food and Drug Administration (FDA) approval for the ODACTRA Tablet, a sublingual treatment using house dust mite allergen extract, for managing allergic rhinitis induced by house dust mites in individuals aged 12 to 17, as well as adults aged 18 to 65. It is an allergen extract and is indicated for immunotherapy in cases of allergic rhinitis induced by house dust mites (HDM), with or without conjunctivitis.
The global house dust mite allergy market is concentrated, with a few large players operating in the market. The top ten competitors in the market made up to 43.1% of the total market in 2022.
House Dust Mite Allergy Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global house dust mite allergy market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for house dust mite allergy treatment products? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The house dust mite allergy market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider house dust mite allergy market; and compares it with other markets.
The report covers the following chapters
- Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product type, by treatment type, by diagnosis and by end users.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the house dust mite allergy market.
- Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product type, by treatment type, by diagnosis and by end users in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size And Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations-This section includes recommendations for house dust mite allergy treqtment products providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered:
- 1) By Product: Tablets; Nasal Drops
- 2) By Treatment: Medication; Nasal Irrigation; Other Types
- 3) By End Users: Pharmacists; Homecare; Clinics; Other End Users
- 4) Diagnosis: Skin Prick Test (SPT); Specific Immunoglobulin E (Ige) Blood Test; Other Diagnostics
- Companies Mentioned: Sanofi SA; Teva Pharmaceutical Industries LTd; Bayer AG; Johnson and Johnson; Merck & Co. Inc.
- Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; house dust mite allergy market indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.